| Quarterly Financials | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 14 | 27 | 18 | 32 | 25 | 31 |
| Expenses | 9 | 18 | 13 | 18 | 18 | 18 |
| EBITDA | 6 | 9 | 5 | 14 | 7 | 12 |
| Operating Profit % | 39 % | 32 % | 29 % | 43 % | 27 % | 40 % |
| Depreciation | 1 | 0 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 1 | 1 | 1 | 1 |
| Profit Before Tax | 5 | 8 | 4 | 13 | 5 | 10 |
| Tax | 1 | 2 | 1 | 3 | 1 | 2 |
| Net Profit | 3 | 7 | 3 | 9 | 4 | 8 |
| EPS in ₹ | 0.55 | 1.05 | 0.51 | 1.53 | 0.59 | 1.34 |
Gaudium IVF & Women Health
Gaudium IVF & Women Health
99.54
-2.03
(-2.00%)
Market Cap
724.52 Cr
PE Ratio
30.10
Volume
1,30,673.00
Day High - Low
99.54 - 99.54
52W High-Low
133.00 - 69.18
Key Fundamentals
Market Cap
724.52 Cr
EPS
3.92
PE Ratio
30.10
PB Ratio
4.83
Book Value
20.92
EBITDA
37.71
Dividend Yield
0.00 %
Industry
Healthcare Sector
Healthcare Service Provider Return on Equity
41.31
Debt to Equity
0.52
Actual
Company News
View All News
Gaudium IVF and Women Health Limited will host a virtual analyst meet on June 12, 2026, organized by Choice Broking. Discussions will rely on publicly available information.
NCLT New Delhi rejected an insolvency petition filed by Ramaa Capital against Gaudium IVF and Women Health Limited. The order dated May 15, 2026, was received on May 22, 2026.
Gaudium IVF board meets on May 28
May 22, 2026
May 22, 2026Gaudium IVF board to meet on May 28 to consider audited financial results for FY26. Trading window closed from April 1.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,601.50 | #1 26,833.94 | 52.41 | #1 2,762.90 | 8.15 | #1 510 | -14.98 | 55.74 | |
1,287.20 | 13,244.87 | 76.07 | 814.20 | 16.36 | 182 | 37.25 | 54.17 | |
530.70 | 11,002.88 | 56.37 | 1,645.85 | 22.25 | 185 | 74.66 | 53.04 | |
528.90 | 8,418.25 | 50.82 | 846.00 | 20.48 | 163 | #1 125.46 | 63.61 | |
748.15 | 7,506.99 | 97.23 | 998.85 | 29.74 | 62 | 22.09 | 75.99 | |
534.30 | 1,733.20 | 17.01 | 772.77 | 4.05 | 106 | 101.45 | 37.40 | |
268.05 | 1,396.02 | 44.13 | 310.41 | 21.30 | 34 | -13.89 | 37.61 | |
633.90 | 1,238.84 | #1 16.99 | 498.18 | #1 237.06 | 69 | 65.45 | 71.70 | |
1,245.40 | 1,068.89 | 17.93 | 141.92 | 27.17 | 61 | 22.50 | 52.53 | |
280.90 | 893.56 | -617.56 | 1,319.27 | 12.68 | -3 | -173.86 | 42.07 |
Growth Rate
Revenue Growth
46.99 %
Net Income Growth
28.06 %
Cash Flow Change
153.49 %
ROE
-17.21 %
ROCE
-15.64 %
EBITDA Margin (Avg.)
-11.61 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 18 | 37 | 57 | 89 | 193 |
| Fixed Assets | 4 | 18 | 19 | 18 | 29 |
| Current Assets | 14 | 18 | 38 | 54 | 73 |
| Capital Work in Progress | 0 | 0 | 0 | 7 | 0 |
| Investments | 0 | 0 | 0 | 5 | 4 |
| Other Assets | 14 | 18 | 39 | 58 | 0 |
| Total Equity & Liabilities | 18 | 37 | 57 | 89 | 193 |
| Current Liabilities | 6 | 10 | 20 | 38 | 39 |
| Non Current Liabilities | 3 | 4 | 4 | 4 | 2 |
| Total Equity | 9 | 23 | 33 | 46 | 152 |
| Reserve & Surplus | 8 | 22 | 32 | 16 | 116 |
| Share Capital | 1 | 1 | 1 | 31 | 36 |
Cash Flow
| Cash Flow | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 14 | -3 | -5 |
| Investing Activities | -1 | -16 | -5 | -15 |
| Operating Activities | -1 | 24 | 3 | 9 |
| Financing Activities | 3 | 5 | -1 | 2 |
Share Holding
| % Holding | Jan 2025 | Sept 2025 | Feb 2026 | Mar 2026 |
| Promoter | 99.98 % | 99.98 % | 71.29 % | 71.29 % |
| FIIs | 0.00 % | 0.00 % | 9.24 % | 6.70 % |
| DIIs | 0.00 % | 0.00 % | 5.11 % | 2.62 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 0.00 % | 13.52 % | 14.67 % |
| Others | 0.02 % | 0.02 % | 0.84 % | 4.73 % |
| No of Share Holders | 7 | 7 | 7 | 19,854 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 18 Mar 2026 |  Quarterly Result Announcement | NA | 18 Mar 2026 | 81.09 | 85.00 |
| 28 May 2026 | Quarterly Result Announcement | NA | 28 May 2026 | 116.74 | 116.79 |
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 29, 2026
May 29, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 29, 2026
May 29, 2026Announcement under Regulation 30 (LODR)-Investor PresentationMay 29, 2026
May 29, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 29, 2026
May 29, 2026Standalone And Consolidated Audited Financial Results For The Quarter And Year Ended March 31 2026May 28, 2026
May 28, 2026Board Meeting Outcome for Board Meeting Outcome For Standalone And Consolidated Audited Financial Results For The Quarter And Year Ended March 31 2026May 28, 2026
May 28, 2026Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 23, 2026
May 23, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 22, 2026
May 22, 2026Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of The Audited Standalone And Consolidated Financial Statements/Results Of The Company For The Quarter And Year Ended March 31 2026.May 22, 2026
May 22, 2026Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 15, 2026
May 15, 2026Clarification On Price MovementApr 16, 2026
Apr 16, 2026Clarification sought from Gaudium IVF and Women Health LtdApr 16, 2026
Apr 16, 2026Intimation Regarding Change Of Corporate Identification Number Of The CompanyApr 15, 2026
Apr 15, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2026
Apr 10, 2026Gaudium IVF And Women Health Limited Has Updated The Exchange On The Query Received From BSE Limited Vide Its Email Dated April 07 2026 Seeking Additional Details For Corporate Announcement Dated April 06 2026 Filed Under Regulation 30 Of SEBI (LODR) ReguApr 07, 2026
Apr 07, 2026Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Apr 06, 2026
Apr 06, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 01, 2026
Apr 01, 2026Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015 ( "Listing Regulations")Apr 01, 2026
Apr 01, 2026Closure of Trading WindowMar 28, 2026
Mar 28, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 19, 2026
Mar 19, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 19, 2026
Mar 19, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMar 18, 2026
Mar 18, 2026Board Meeting Outcome for Board Meeting Outcome For Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Mar 18, 2026
Mar 18, 2026Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Mar 18, 2026
Mar 18, 2026Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025Mar 12, 2026
Mar 12, 2026Intimation Under Regulation 8(2) Of The Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015Mar 02, 2026
Mar 02, 2026Intimation Under Regulation 7(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)Mar 02, 2026
Mar 02, 2026Intimation Under Regulation 6(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 02, 2026
Mar 02, 2026Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("SEBI Listing Regulations")Mar 02, 2026
Mar 02, 2026Closure of Trading WindowMar 02, 2026
Mar 02, 2026Listing of Equity Shares of Gaudium IVF and Women Health LtdFeb 27, 2026
Feb 27, 2026Technical Indicators
RSI(14)
Neutral 39.94
ATR(14)
Less Volatile 4.45
STOCH(9,6)
Oversold 2.23
STOCH RSI(14)
Oversold 6.50
MACD(12,26)
Bearish -1.91
ADX(14)
Weak Trend 14.58
UO(9)
Bullish 23.05
ROC(12)
Downtrend And Accelerating -15.31
WillR(14)
Oversold -100.00
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
